ALXN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Alexion Pharmaceuticals Inc's quarterly cash and cash equivalents declined from Jun. 2013 ($936 Mil) to Sep. 2013 ($910 Mil) and declined from Sep. 2013 ($910 Mil) to Dec. 2013 ($530 Mil).
Alexion Pharmaceuticals Inc's annual cash and cash equivalents increased from Dec. 2011 ($541 Mil) to Dec. 2012 ($990 Mil) but then declined from Dec. 2012 ($990 Mil) to Dec. 2013 ($530 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Alexion Pharmaceuticals Inc Annual Data
Alexion Pharmaceuticals Inc Quarterly Data